What do we know about the OpenAI IPO

OpenAI completed its restructuring on October 28, 2025, converting its capped-profit LLC subsidiary into Delaware Public Benefit Corporation (PBC) OpenAI Group PBC while preserving nonprofit control through special governance rights.[1][2]

The nonprofit (renamed OpenAI Foundation) holds a 26% equity stake valued at approximately $130 billion at the time of closing, plus a warrant for additional shares if valuation milestones are met, alongside Microsoft’s roughly 27% stake and 47% held by employees and other investors.[2]

Timeline of the Conversion

OpenAI began as a Delaware nonprofit in 2015 and created a capped-profit LLC subsidiary in 2019 that remained under nonprofit control.[1]

• December 27, 2024: OpenAI publicly outlined plans to restructure the for-profit arm into a Delaware PBC to enable conventional capital raising, initially signaling potential shifts away from direct nonprofit oversight.[3]
• Early-to-mid 2025: Following feedback from civic leaders and Attorneys General, OpenAI revised the plan in May 2025 to ensure the nonprofit retained control while becoming a major equity holder.[4]
• October 27–28, 2025: California and Delaware Attorneys General completed reviews and issued clearances (detailed below); the Delaware Division of Corporations approved the 30-page Certificate of Incorporation for OpenAI Group PBC on October 28 at 8:07 a.m. OpenAI announced the recapitalization’s completion the same day.[5][6]

No public court approvals or litigation resolutions were required; the process relied on Attorney General non-objection after extended review.

Regulatory Process and Filings

Delaware and California Attorneys General conducted parallel reviews starting in late 2024 (Delaware AG review initiated October 9, 2024), focusing on mission primacy, nonprofit control, fair valuation, and safety commitments.[6]

Key documents include:
- Delaware AG’s October 28, 2025, Statement of No Objection, conditioned on specific representations (e.g., Class N stock governance rights, mission alignment, safety fiduciary overrides).[7]
- California AG MOU signed October 27, 2025, memorializing conditions of non-objection, including headquarters location, notice requirements for major changes, and safety provisions.[8]
- OpenAI’s Certificate of Incorporation (filed and approved in Delaware on October 28, 2025), establishing the PBC with a stated public benefit mission identical to the nonprofit’s.[5]

Opposition included expert letters urging intervention on mission dilution grounds, but approvals proceeded with concessions.[9]

Post-Conversion Governance Rights Retained by the Nonprofit

The OpenAI Foundation retains structural control despite minority equity ownership via Class N Common Stock and special voting/governance rights embedded in the PBC charter.[7]

• Board control: Sole power to appoint and remove all directors of OpenAI Group PBC at any time; the nonprofit board initially overlaps substantially with the PBC board (with phased separation for the Safety and Security Committee chair and at least one additional director within one year).[2]
• Veto/approval rights: Prior written approval required for amendments to corporate governance documents or the public benefit article, mission changes, certain major transactions (e.g., deemed liquidation events or material asset sales), issuance of additional Class N shares, creation of new director-voting stock classes, or modifications disproportionately affecting Class N rights.[7]
• Safety and mission primacy: On safety/security issues (including Safety and Security Committee actions), PBC directors must consider only the mission and may not weigh pecuniary stockholder interests.[7]
• Equity and upside: 26% stake (~$130 billion at closing valuation) plus a warrant for significant additional shares if share price exceeds a threshold after 15 years (scaling with outperformance beyond 10x).[2]
• Other: Mission must remain identical; PBC must publish the OpenAI Charter and balance shareholder/stakeholder/public benefit interests per Delaware PBC law.

These rights are not tied solely to equity percentage and persist as long as the Foundation holds the Class N shares (a decision controlled by the nonprofit board).[7]

Changes from the Prior Capped-Profit Structure

The prior setup featured a nonprofit-controlled capped-profit LLC with limited investor returns (capped at a multiple of investment) and more direct subsidiary oversight. The new PBC removes the profit cap, issues conventional common stock participating proportionally in value growth, and shifts to a hybrid model where the nonprofit exerts control through charter rights rather than sole subsidiary ownership.[3]

This aligns incentives (nonprofit gains from growth via equity) while codifying the dual mandate in the corporate charter. The nonprofit’s role evolves from primary controller of operations to mission guardian with substantial economic participation and board appointment authority.

Implications for IPO, Direct Listing, or SPAC

The PBC structure facilitates traditional IPOs, direct listings, or other public offerings by replacing the atypical capped-profit LLC with standard equity shares that appeal to conventional investors, while the public benefit purpose is a required but manageable charter element under Delaware law.[10]

PBC directors must balance the stated benefit (here, the AGI mission) with other interests, creating potential disclosure and fiduciary considerations in SEC filings, but it does not legally prohibit public trading or stock-based acquisitions. As of June 2026, OpenAI had reportedly made confidential SEC filings in preparation for a potential IPO (timing eyed for late 2026 or 2027, subject to market conditions), positioning it alongside peers like Anthropic.[11][12]

For entrants or competitors: Replicating this hybrid (nonprofit control via special shares + PBC operations + equity participation) requires navigating state AG reviews in Delaware/California (or equivalents), independent valuations, and safety/mission commitments. It offers a template for mission-driven AI labs seeking scale without fully relinquishing oversight, but demands significant legal/financial structuring and regulator engagement. Pure for-profits or standard nonprofits face different capital and governance trade-offs.

Recent Findings Supplement (June 2026)

OpenAI completed its recapitalization into a Delaware Public Benefit Corporation (PBC) structure on October 28, 2025, with the nonprofit (renamed OpenAI Foundation) retaining control and a ~26% equity stake (~$130 billion at the time, plus milestone-based additional ownership). This followed reviews and non-objection by the Delaware and California Attorneys General, who secured enforceable commitments on mission alignment, board control, and oversight. The PBC (OpenAI Group PBC) replaced the prior capped-profit LLC, removing profit caps while embedding the mission in the charter.[1][2]

Recent developments (primarily 2026) center on how this structure positions the company for public markets rather than any alterations to the governance or filings from the 2025 conversion.

The June 2026 confidential S-1 filing marks the first major post-conversion milestone, explicitly treating the PBC structure as a prerequisite for traditional equity markets. OpenAI (via OpenAI Group PBC) confidentially submitted a draft S-1 registration statement to the SEC around May–June 2026 (publicly noted June 8, 2026), giving it the option to pursue an IPO potentially as early as Q4 2026 or later, though timing remains fluid and some reports suggest possible delays into 2027. The filing must address the nonprofit-to-PBC conversion, ongoing governance rights, and mission constraints in the prospectus—creating disclosure and valuation complexities unique among AI peers.[3][4]

• The PBC form provides conventional share classes and removes the capped-profit hybrid that markets struggled to price, enabling standard IPO, direct listing, or (theoretically) SPAC paths.
• Delaware PBC law requires balancing stockholder interests with the public benefit (here, the AGI mission) and affected parties; the charter further mandates prioritizing the mission (especially safety/security) over pecuniary interests in relevant decisions.
• No public details have emerged on exact prospectus language or investor pricing of the nonprofit control/equity layer.

Nonprofit governance rights remain unchanged since the October 2025 close and continue to constrain (or enable) public-market options through board control and veto rights. The OpenAI Foundation holds Class N Common Stock granting sole authority to appoint and remove the entire PBC board. It also holds veto/approval rights (requiring prior written consent) on mission amendments, major asset sales/liquidation events, additional Class N share issuance, creation of new voting stock classes, and disproportionate adverse amendments to Class N rights. The PBC mission is identical to the Foundation’s, with specific charter provisions insulating safety/security decisions from stockholder pecuniary interests.[5][6]

• This hybrid (minority economic stake + majority control via Class N) differs from the pre-2025 structure, where the nonprofit fully oversaw a capped-profit subsidiary without the same equity upside or PBC statutory balancing requirements.
• AG agreements (Delaware Statement of No Objection and California MOU, both October 2025) added ongoing obligations, including advance notice to regulators for control changes, mission amendments, or headquarters relocation outside California.
• These features make a traditional IPO feasible (standard corporate form + mission baked in) but introduce ongoing fiduciary and disclosure layers that could affect valuation, investor appetite, or activist challenges—unlike a pure for-profit C-corp. SPAC or direct listing paths would face similar mission and control disclosures.

No new Delaware or California regulatory filings, court approvals, or AG reviews have been reported since the October 2025 non-objections and Certificate of Incorporation filing for OpenAI Group PBC. The structure has remained stable through mid-2026, with the PBC model aligning OpenAI with peers like Anthropic (also a PBC). A June 2026 Florida lawsuit naming OpenAI Group PBC and related entities addresses unrelated consumer claims and does not challenge the conversion.[7]

For competitors or entrants, the OpenAI precedent shows that a mission-driven PBC with retained nonprofit control can clear regulatory hurdles for IPO readiness while preserving founder/nonprofit influence, but it requires extensive AG negotiation, independent fairness opinions, and charter-level protections. Public markets will now price this hybrid explicitly via the S-1 process, potentially setting terms for how control premiums or mission constraints are valued in future AI listings. Ongoing AG oversight commitments add a layer of external accountability not present in standard PBCs.

Stargate LLC is a Delaware-incorporated joint venture (JV) announced on January 21, 2025, at a White House event with President Trump, OpenAI CEO Sam Altman, SoftBank CEO Masayoshi Son, and Oracle co-founder Larry Ellison. It targets up to $500 billion in U.S. AI data center and power infrastructure (aiming for ~10 GW capacity by ~2029) exclusively or primarily to support OpenAI workloads, with an initial $100 billion deployment phase.[1][1][2]

The $500 billion figure represents an aspirational multi-year investment target (capex across sites, power, and hardware), not a single committed equity pool. Initial committed capital was reported at around $100 billion total (including equity and other sources), with ongoing project finance, debt, limited partners (LPs), and partner contributions filling gaps.[2][3]

Equity stakes and contributions (per reporting citing The Information): OpenAI and SoftBank each committed $19 billion for ~40% ownership; Oracle and MGX (Abu Dhabi investment firm) each committed $7 billion. SoftBank serves as the financial lead and chairman (Masayoshi Son), while OpenAI handles operational responsibility.[2][4][2]

This structure positions the JV as a dedicated vehicle for infrastructure, distinct from OpenAI’s core operations or Microsoft partnership.

Progress has included site announcements and partial buildouts alongside reported delays. The flagship Abilene, Texas campus (Oracle Cloud Infrastructure-backed) became operational with expansions; September 2025 announcements added five U.S. sites (three Oracle-led, two SoftBank-led), pushing planned capacity toward ~7 GW and >$400 billion in associated investment, with claims of being ahead of schedule for the full target by end-2025.[5][6]

However, February 2026 reporting (The Information and others) indicated the JV itself had not hired staff or actively developed centers under the Stargate LLC entity due to disputes over site ownership, control, and responsibilities among OpenAI, Oracle, and SoftBank. OpenAI pivoted toward bilateral deals (e.g., direct Oracle capacity agreements, NVIDIA hardware/equity ties). Some international mentions (UAE, Argentina) appeared but remained secondary to U.S. focus.[7][8]

Subsequent funding and infrastructure elements include SoftBank-related loans/project finance (e.g., Mizuho borrowing, JPMorgan lending for Abilene), NVIDIA commitments (up to $100 billion equity tied to GW deployments), Oracle’s multi-GW capacity deals and power procurement, and SoftBank/OpenAI co-investments in power entities like SB Energy.[2][9]

The JV’s separate capital structure likely reduces OpenAI’s immediate need for massive public equity raises specifically for infrastructure. OpenAI’s $19 billion equity commitment is substantial but bounded, while SoftBank leads financing, the JV accesses debt/LP capital, and partners (Oracle for cloud/architecture, NVIDIA for hardware) contribute directly or via milestone-tied deals. This offloads much of the $500 billion-scale capex intensity from OpenAI’s balance sheet to the JV entity.[10]

However, it does not eliminate OpenAI’s broader capital needs—ongoing model development, talent, operations, and any residual compute costs or overruns still require funding. OpenAI has continued large private rounds (e.g., $40 billion SoftBank-led earlier, later $110+ billion rounds including Amazon, NVIDIA, and SoftBank tranches, some explicitly tied to Stargate milestones), suggesting the JV mitigates but does not fully replace equity demands.[11]

Investor disclosures reflect this dynamic: SoftBank has highlighted its OpenAI investments (completed tranches reaching $40 billion by late 2025/early 2026, with portions linked to Stargate) in filings and releases; Oracle’s backlog/RPO (hundreds of billions reported in earnings contexts) and debt raises explicitly reference Stargate/OpenAI AI infrastructure opportunities and OCI growth.[12][13]

Sam Altman’s public statements on IPO timing emphasize flexibility tied to business needs rather than a fixed race, with explicit references to capital requirements. Key dated examples include:

• November 2025 (WSJ reporting on CFO Sarah Friar): OpenAI “isn’t yet working toward an IPO.”[14]
• February 2026 (AI Impact Summit comments): “Don’t know about the visibility for a 2026 IPO, but we will be a public company some day.”[15]
• June 1, 2026 (CNBC report from Stargate Michigan groundbreaking event, post-Anthropic filing): “I think there is a race to deliver the best technology and build the best business, but going public is a financing event, and I don’t think that’s one that we’re focused on the timing of.” Altman added that OpenAI will pursue an IPO “when it makes sense for the company” and is “not focused on the timing.”[16][17]

Rationale across statements and reporting centers on aligning with growth plans, capital needs for scaling (including infrastructure ambitions), and operational readiness; some reports note internal CFO concerns about 2026 readiness (reporting standards, spending risks) and expectations of potential slippage to early 2027, with bankers engaged for a potential $1T+ valuation.[18]

Overall, Stargate’s JV structure provides a mechanism to distribute infrastructure financing risk and execution across partners and debt markets, which could modestly ease OpenAI’s path to public markets by reducing one major capital sink. Yet persistent private fundraising, reported JV frictions, and Altman’s framing of IPO as a “financing event” indicate it has not removed the underlying pressure from OpenAI’s compute-intensive model—potentially preserving or even heightening the case for eventual public equity access once milestones or market conditions align. Cross-referenced SoftBank and Oracle disclosures treat Stargate-related commitments as strategic growth drivers rather than fully ring-fenced off-balance-sheet items for OpenAI.

Recent Findings Supplement (June 2026)

Stargate LLC (the JV formed by OpenAI, SoftBank, Oracle, and MGX) remains largely stalled as a coordinated entity into mid-2026, with partners shifting to bilateral deals amid disputes, while site-level construction advances separately.[1]

The $500 billion headline commitment (announced January 2025 at the White House, targeting 10 GW U.S. capacity by ~2029) has seen limited JV-specific execution. Initial equity commitments reportedly included OpenAI and SoftBank each at ~$19 billion (40% ownership each), with Oracle and MGX contributing a combined ~$7 billion; the balance was to come from limited partners and debt.[2] Confirmed near-term capital is closer to the initial $100 billion scale, with OpenAI previously citing over $400 billion “in play” via the broader ecosystem (pre-2026 statements). As of February 2026 reporting, the JV itself had hired no staff and developed no data centers, prompting OpenAI to route around it.[3]

• Key mechanism of stalling: Partners disagreed on site ownership/control, financing responsibilities, and operational structure. OpenAI initially pushed for more independent ownership to reduce third-party cloud reliance but encountered resistance over upfront costs and its own projected cash needs by mid-2027.[1]
• Bilateral progress includes Oracle’s $300 billion/5-year compute purchase agreement (up to 4.5 GW, announced mid-2025) and SoftBank-led sites (e.g., Lordstown, OH; Milam County, TX, scaling to ~1.5 GW). Abilene, TX flagship (Oracle-overseen) has partial operations since September 2025, with full ~1–1.2 GW capacity targeted for mid-to-end 2026.[4]
• Additional 2026 activity: OpenAI/SoftBank each invested $500 million ($1 billion total) in SB Energy (January 2026) for power infrastructure; Michigan Stargate campus groundbreaking occurred around June 2026.[4]

Sam Altman’s most recent public statements (June 1, 2026) downplay IPO timing urgency, framing it strictly as a financing event rather than a strategic milestone.[5]

Speaking at the Michigan Stargate groundbreaking, Altman stated there is “a race to deliver the best technology and build the best business, but going public is a financing event, and I don’t think that’s one that we’re focused on the timing of.” He added OpenAI will pursue an IPO “when it makes sense for the company,” shrugging off comparisons to Anthropic’s filing.[5]

• Earlier 2026 commentary (February) showed less certainty on a 2026 timeline (“I don’t know. The visibility for that?”) while affirming OpenAI would eventually go public.[6]
• Reports through mid-2026 indicate internal tension, including between Altman and CFO Sarah Friar, over readiness and timing, with some speculation of a potential push into 2027 amid capital demands.[7]

Stargate’s structure as a separate JV with dedicated partner capital (especially SoftBank’s financial lead role) primarily reduces OpenAI’s near-term need to access public equity markets for infrastructure.[2]

By offloading the bulk of the multi-hundred-billion-dollar capex and power buildout to the JV and bilateral partner commitments, OpenAI can prioritize model development and operations while partners absorb construction and financing risks. However, the JV’s stalled coordination has forced OpenAI into additional direct funding (e.g., SoftBank’s $41 billion investment in OpenAI itself in December 2025) and other cloud deals, partially offsetting the benefit.[4]

Oracle and SoftBank investor disclosures and public updates provide limited granular JV-specific detail beyond headline commitments and bilateral contracts. SoftBank has highlighted its financing role and the $41 billion OpenAI stake (December 2025), while Oracle has referenced large compute backlogs tied to OpenAI (including the $300 billion agreement). No major new regulatory filings or updated ownership breakdowns have surfaced in recent sources to contradict the earlier 40%/40% OpenAI-SoftBank split.[2]

Implications for competitors or entrants: The JV’s coordination challenges highlight execution risks in mega-scale AI infrastructure consortia, favoring entities with stronger bilateral leverage (e.g., hyperscalers or specialized developers). OpenAI’s continued capital needs despite the JV suggest infrastructure financing remains a persistent pressure point even with partner capital in place. Direct investment in Stargate itself is unavailable to most; indirect exposure is limited to stakes in partners like OpenAI (private secondary markets), SoftBank, or Oracle.[2]

All quantitative claims above draw from sources published or updated after December 28, 2025, with emphasis on February–June 2026 reporting. Earlier 2025 announcements (e.g., five new sites in September 2025) are excluded as non-new.

As of late June 2026, OpenAI faces layered regulatory and legal pressures centered on its 2025 restructuring from a nonprofit-controlled capped-profit entity to a public benefit corporation (PBC) structure (with the nonprofit retaining significant control, e.g., ~26% stake in some reports), its Microsoft partnership, data/privacy practices, consumer impacts (especially on minors), and governance. These stem primarily from state attorneys general rather than a singular high-profile FTC probe into the conversion itself. Antitrust scrutiny focuses more on AI partnerships than the conversion per se. Elon Musk’s lawsuit was dismissed on statute-of-limitations grounds in May 2026. OpenAI confidentially filed draft S-1 paperwork with the SEC around June 8, 2026, signaling IPO ambitions (potentially late 2026 or 2027 at ~$850B–$1T valuation), but ongoing matters create disclosure, timing, and governance risks.[1][2]

No dedicated, active FTC civil investigative demand or formal probe specifically targeting the nonprofit-to-for-profit (or PBC) conversion appears in public reporting as of mid-2026. Earlier FTC actions (2023 CID on privacy/data security and broader 6(b) studies on AI partnerships) and joint FTC/DOJ antitrust reviews of Microsoft-OpenAI arrangements provide indirect overlap, but conversion scrutiny has been led by states.[3][4]

FTC and DOJ Antitrust Scrutiny on AI Partnerships

Federal enforcers have evolved preliminary 2024 inquiries into more formal reviews of AI ecosystem concentration, with OpenAI’s Microsoft relationship a focal point due to cloud exclusivity, bundling, talent sharing, and “circular” financing concerns.[4][4]

• By 2026, the FTC (under evolving leadership) and DOJ are conducting active antitrust investigations into Microsoft-OpenAI dynamics, including bundling practices, licensing terms, and market access effects; similar scrutiny applies to other AI deals (e.g., Nvidia-OpenAI compute partnerships).[4]
• Broader context includes 6(b) studies on cloud-AI ties and warnings against using AI disruption claims without evidence in merger reviews.[5]
• No enforcement actions (e.g., complaints or remedies) have been announced against OpenAI specifically, but the investigations remain live.

For an IPO: Ongoing federal antitrust reviews would require prominent risk-factor disclosures in the S-1/ prospectus about potential remedies, partnership constraints, or valuation impacts. This could delay roadshows if document production or comments intensify, or pressure the Microsoft economics narrative that underpins much of OpenAI’s infrastructure advantage. Investors may apply a discount (historical precedents suggest 15-25% compression in uncertain regulatory environments).[6]

Multistate and California/Delaware Attorney General Proceedings

A broad coalition of state AGs (reports cite ~42 states) launched a sweeping investigation in June 2026, issuing subpoenas shortly after OpenAI’s confidential IPO filing. This builds on earlier 2025 inquiries by California (headquarters) and Delaware (incorporation state) into the conversion.[6][6][7]

• In late 2025, CA AG Rob Bonta and DE AG Kathy Jennings scrutinized the nonprofit-to-PBC shift for compliance with charitable asset dedication rules; they ultimately entered into agreements/MOUs (around Oct 2025) that permitted the restructuring while addressing mission-protection concerns.[8]
• The June 2026 multistate probe (led in part via NY AG subpoena) seeks documents on the conversion structure/valuation, advertising, user/consumer/health data practices, treatment of minors and seniors, deep learning models, “model sycophancy,” safety policies, and internal representations—explicitly touching the nonprofit origins and PBC commitments. OpenAI stated it is engaging “constructively” and taking concerns “seriously.”[9][7]
• Advocacy coalitions have urged CA AG Bonta to revisit the 2025 deal in light of evidence from the Musk trial.[10]
• Related state actions include isolated probes (e.g., Florida criminal investigation tied to a specific incident; CA scrutiny of other AI firms on child safety).[11]

For an IPO: The open-ended multistate investigation (no fixed timeline) directly implicates the conversion narrative central to OpenAI’s governance story. Subpoena responses and any findings must be disclosed as material risks or litigation matters in SEC filings. Successful challenges to the conversion could theoretically unwind elements of the structure or impose conditions, creating existential uncertainty. Even without escalation, it amplifies “AI-washing” or consumer-protection exposure, potentially requiring enhanced safety/governance disclosures and deterring certain institutional investors. The probe’s breadth overlaps with SEC review, raising the prospect of referrals.[6]

Elon Musk Litigation Against OpenAI

Musk’s 2024 federal lawsuit (alleging breach of the original nonprofit mission and improper for-profit shift) proceeded to trial but was resolved in OpenAI’s favor on procedural grounds.[12]

• Trial occurred in April–May 2026 in U.S. District Court (Oakland, CA) before Judge Yvonne Gonzalez Rogers; evidence included internal notes from OpenAI executives.[11]
• On May 18, 2026, a jury unanimously found claims barred by the statute of limitations (Musk allegedly knew of plans years earlier); the judge dismissed the case. Musk indicated plans to appeal.[13][14]
• The outcome was viewed as removing a significant overhang for IPO planning.[15]

For an IPO: Resolution clears a major litigation cloud and supports cleaner disclosures. However, any appeal (or related public statements) could be noted as a contingent risk. The trial itself generated evidence that advocacy groups have used to pressure state AGs on the conversion, indirectly fueling the multistate probe.[10]

SEC Commentary on AI Disclosures and Non-Standard Structures

The SEC has not issued OpenAI-specific commentary, but broader developments emphasize enhanced AI-related disclosures and scrutiny of complex governance. OpenAI’s confidential S-1 filing subjects it to standard SEC review processes.[1]

• The SEC Investor Advisory Committee has recommended guidance on AI disclosures, including defining AI, board oversight mechanisms, and material effects on operations/consumer matters (building on cybersecurity rules).[16][17]
• Proposals and analyses advocate materiality-based regimes: dedicated AI risk/incident reporting (e.g., 8-K items), 10-K sections on governance/risks/dependencies, and enforcement against misleading “AI-washing.”[18]
• OpenAI’s PBC structure (balancing profit with a public benefit mission, under nonprofit influence) is non-standard for a major public company; PBCs require periodic public benefit reporting, and dual fiduciary duties could necessitate detailed governance, control, and conflict disclosures.[19]

For an IPO: SEC review of the draft S-1 will likely demand robust risk factors on regulatory investigations, data practices, model risks/safety, compute dependencies, Microsoft relationship, and the hybrid governance structure (nonprofit control over a for-profit entity raises questions about mission drift, asset allocation, and investor rights). Any state AG findings could trigger supplemental comments or delays. The non-standard setup may prolong comment resolution compared to conventional tech IPOs, though confidential filing allows private iteration.[6]

Overall Implications for a Public Offering

These matters create a multi-front risk profile that could extend the path from confidential filing to listing (OpenAI has signaled flexibility on timing, with some reports leaning toward 2027). Key mechanisms include mandatory risk disclosures that highlight uncertainty, potential consent decrees or structural conditions from states, and investor skepticism around governance stability or partnership durability. Antitrust or multistate outcomes could also indirectly affect revenue projections or partnerships disclosed in the prospectus.[20]

OpenAI’s response—cooperation statements and prior state agreements—suggests efforts to mitigate, but the June 2026 subpoenas indicate momentum. Competitors and investors will monitor document production closely for competitive or valuation signals. Additional research into specific subpoena returns or SEC comment letters (once public) would provide further clarity.

Recent Findings Supplement (June 2026)

As of mid-2026 (focusing on developments after December 28, 2025), OpenAI faces ongoing multistate attorney general scrutiny centered on its nonprofit-to-public benefit corporation (PBC) restructuring, data practices, and child safety—intensified by its June 2026 confidential S-1 filing—alongside active federal antitrust investigations into its Microsoft relationship. Elon Musk’s related lawsuit was dismissed in May 2026 on statute-of-limitations grounds, though an appeal is planned. No major new FTC-specific action on the conversion itself or fresh SEC guidance on AI disclosures/non-standard structures emerged in this period.[1][1]

Multistate and State AG Scrutiny (Including California and Delaware)

A coalition of 42 state attorneys general launched a coordinated investigation in June 2026, issuing subpoenas to OpenAI within days of its confidential S-1 filing (around June 8, 2026). The probe targets the nonprofit-to-PBC conversion (including asset valuation, structure, and enforceability of public benefit commitments), user data practices, AI model capabilities/safety representations, internal safety policies, advertising, and risks to minors. California (AG Rob Bonta) and Delaware (AG Kathy Jennings) have been central, with the broader coalition (including New York, Colorado, Texas, and others) operating under consumer protection and UDAP authorities.[2][3]

• Delaware completed its review of the recapitalization in October 2025 with a “Statement of No Objection” after securing safety and mission-related commitments via MOU; this framework carried into 2026 scrutiny.[1]
• In early June 2026, the Eyes on OpenAI coalition urged California AG Bonta to revisit prior agreements in light of evidence from the Musk trial, arguing insufficient protection for the charitable mission and assets.[4]
• OpenAI stated it is engaging “constructively” and takes concerns “seriously,” noting added safeguards like parental controls in ChatGPT.[3]

Timeline and IPO impact: The investigation lacks a fixed deadline and could extend into or beyond any public offering process (targeted for late 2026 or 2027). Successful challenges to the conversion could force structural changes, additional disclosures, consent decrees limiting practices, or litigation that introduces open-ended liability and risk-factor prominence in the prospectus—potentially compressing valuation (precedents suggest 15-25% discounts from regulatory uncertainty) or delaying the IPO. Subpoenaed documents risk leakage to competitors or SEC referral on disclosure inconsistencies.[2]

FTC and DOJ Antitrust Review

By 2026, earlier FTC 6(b) inquiries (from 2024) into AI partnerships evolved into formal, active joint FTC-DOJ antitrust investigations focused on OpenAI’s relationship with Microsoft, including bundling practices, software licensing terms, support economics, and competitive impacts. FTC leads on Microsoft/OpenAI conduct; DOJ has taken Nvidia-related aspects.[1][1]

No major new enforcement actions or resolutions were reported in early-mid 2026, but the scrutiny remains live amid OpenAI’s restructuring and IPO preparations.

Timeline and IPO impact: Investigations are ongoing without a specified endpoint. Remedies could include behavioral changes, limits on exclusive arrangements, or structural adjustments affecting the Microsoft partnership (a key investor and compute provider), introducing operational complexity, higher compliance costs, or valuation pressure. This adds to risk factors in any S-1 and could delay or condition a public offering if enforcement escalates.[1]

Elon Musk Litigation Against OpenAI

The high-profile federal lawsuit (Musk v. Altman et al.) proceeded to trial in Oakland federal court starting April 27, 2026, with Musk alleging breach of the original nonprofit mission, fraud, and related claims tied to the for-profit transition. Key developments included testimony from figures like Greg Brockman and Shivon Zilis, and Musk amending demands (e.g., removing Altman from the board).[5]

On May 18, 2026, a jury unanimously found all claims barred by the statute of limitations after less than two hours of deliberation; the judge dismissed the case. Musk described it as a “calendar technicality” and vowed to appeal to the 9th Circuit.[6][7]

Timeline and IPO impact: Dismissal removed a direct pre-IPO litigation overhang and potential governance disruption, but the appeal process and trial publicity amplified scrutiny on the conversion (fueling state AG actions and coalition letters). Any reversal could reintroduce mission-related claims or demands for structural reversal, complicating governance disclosures and shareholder alignment in a public company.[1]

SEC Commentary on AI Disclosures and Non-Standard Structures

OpenAI confidentially submitted a draft S-1 registration statement to the SEC around June 8, 2026, marking the formal start of the IPO review process (no public filing or detailed financials released yet). No new, specific SEC guidance or commentary on AI company disclosures or non-standard structures (such as PBC/nonprofit hybrids) was identified in 2026 sources beyond references to the agency’s existing 2024 framework on AI-related risks and limitations.[8][2]

The unique governance setup—nonprofit (OpenAI Foundation) holding ~26% stake with appointment/removal power over the PBC board, a mission-identical charter, and an independent Safety and Security Committee (under nonprofit control) with authority to halt model releases even against commercial interests—will require detailed risk-factor and governance disclosures in the prospectus. This structure creates potential conflicts where safety/mission priorities can legally override shareholder value, an untested dynamic in public markets that could invite SEC comments, investor pushback, or delays during review.[1]

Overall IPO implications: These overlapping probes and the hybrid structure introduce material uncertainties around governance enforceability, compliance costs, potential remedies, and disclosure risks that could extend SEC review timelines, require supplemental filings, or lead to pricing/valuation adjustments. State actions, being independent of federal securities processes, pose particular scheduling friction. OpenAI’s engagement with regulators and the Musk case resolution provide some mitigation, but outcomes remain fluid as of late June 2026.

OpenAI's revenue run rate reached approximately $24–25 billion ARR by early-to-mid 2026, driven by rapid scaling of ChatGPT consumer subscriptions, enterprise adoption (now >40% of revenue), and an emerging ads business.[1][2]

OpenAI's own March 2026 update stated it was generating $2 billion in monthly revenue (implying a ~$24 billion annualized run rate), with enterprise contributing more than 40% and on track for parity with consumer by year-end. Ads pilots hit $100 million ARR in weeks. This aligns with third-party estimates from Sacra ($25 billion ARR in February 2026, up from $20 billion at end-2025) and Reuters/The Information ($25 billion+ ARR by end-February 2026, a 17% increase from $21.4 billion at year-end 2025).[3][4]

Full-year 2025 actual revenue was approximately $13.1 billion. Q1 2026 revenue reached $5.7 billion. Growth has been explosive: from ~$2 billion ARR in 2023 and $6 billion in 2024 to $20 billion+ in 2025 and $25 billion+ by March 2026. Enterprise momentum and usage growth (search nearly tripled year-over-year) underpin the trajectory, though some reports note Anthropic briefly surpassing OpenAI on ARR in spring 2026.[5][6]

• Implication for competitors/entrants: The combination of consumer scale + enterprise data moat creates a flywheel; new entrants must match both distribution and inference economics to compete on price or features.

OpenAI remains deeply unprofitable, with Q1 2026 showing a –122% non-GAAP operating margin and $3.7 billion cash burn on $5.7 billion revenue, driven overwhelmingly by compute and inference costs.[5][7]

Gross margins stand at ~33%, constrained by inference costs that totaled $8.4 billion in 2025 and are projected to rise to $14.1 billion in 2026. Cash burn is estimated at ~$27 billion for full-year 2026 (some internal forecasts cite ~$14 billion net loss). The company faces hundreds of billions in long-term compute commitments (recently reset target of ~$600 billion cumulative spend by 2030). It is not expected to reach cash-flow breakeven until ~2030 under current trajectories.[2][8]

• Implication: High fixed/variable compute costs create a capital intensity barrier unlike traditional SaaS; competitors with better hardware efficiency (e.g., custom chips) or lower inference demand can achieve structurally superior unit economics.

The most recent primary round closed March 31, 2026, at an $852 billion post-money valuation after raising $122 billion (led by Amazon, Nvidia, SoftBank). Secondary market pricing in June 2026 implied valuations of roughly $700–900 billion.[1][9]

Forge Global reported a derived price of $721.85 per share as of June 26, 2026 (implying ~$894 billion valuation). Hiive indicated ~$704 per share around the same period. Earlier secondaries included a $500 billion valuation in October 2025 (employee share sales) and implied levels around $600–750 billion in late 2025. Demand for OpenAI shares reportedly softened in secondary markets by spring 2026 as capital rotated toward rivals like Anthropic.[10]

Prior primary rounds included ~$110 billion at $730–840 billion (February 2026) and $40 billion at $300 billion (2025).

OpenAI trades at ~34x ARR on its $852 billion primary valuation (or ~36x on recent secondary levels) for ~$25 billion ARR—broadly in line with high-growth public AI-exposed names like Palantir but at a massive premium to mature SaaS like Salesforce.[11]

Comparative Valuation Table (mid-2026 data)

Palantir commands a comparable premium due to elite growth and Rule of 40 scores (>100%+), while Salesforce reflects mature SaaS realities at low-single-digit multiples. Microsoft's AI revenue benefits from platform scale but faces investor scrutiny on associated capex.[12][13][14]

• Implication: OpenAI's valuation reflects expectations of continued hyper-growth and platform dominance, but sustained losses and compute intensity introduce execution risk not fully priced into public multiples. New entrants or rivals (e.g., Anthropic) are being valued on similar growth narratives but at potentially better unit economics. Public market investors apply discounts for maturity, profitability, and scale, creating a wide gap versus private AI leaders.

Recent Findings Supplement (June 2026)

OpenAI reached a $25 billion ARR run rate by February/March 2026 (up from ~$20 billion at end-2025), with Q1 2026 revenue of $5.7 billion (~$23 billion annualized pace) and a $2 billion monthly run rate cited in its March 2026 update.[1][2][3]

• Sacra and Reuters/The Information reporting (March 2026) pegged the February exit rate at $25 billion ARR, reflecting 17% sequential growth from year-end 2025 levels; enterprise revenue exceeded 40% of the total and was on track for parity with consumer by end-2026.[2][4]
• OpenAI stated it was “on track” for a $30 billion 2026 revenue target, with ads pilot contributing $100 million ARR in weeks and search usage tripling year-over-year.[5][3]
• Full-year 2025 actual revenue was reported around $13.1 billion in multiple analyses.[6]

Q1 2026 losses and margins underscore extreme compute-driven cost pressure: $3.7 billion cash burn on $5.7 billion revenue, with -122% non-GAAP operating margin.[7][5]

• The Information (June 2026) detailed the Q1 burn exceeding half of revenue, alongside $665 billion in long-term computing commitments; earlier internal projections had flagged potential $14 billion full-year 2026 losses.[7]
• R&D and cost-of-revenue lines scaled dramatically (e.g., 2025 R&D reportedly ~$19 billion in leaked analyses), reflecting inference and training costs that outpace revenue growth even as the company scales to hundreds of millions of users.[8]
• Profitability remains distant; cumulative losses through the late 2020s are projected in the tens of billions before any breakeven.

The most recent primary round closed in March 2026 at an $852 billion post-money valuation with $122 billion raised; secondary/Forge markets priced shares implying ~$894–895 billion as of late June 2026.[3][9]

• OpenAI’s own March 31, 2026 announcement detailed the $122 billion round (including large commitments from SoftBank, Nvidia, Microsoft, and others), marking the largest private financing on record at that scale.[3]
• Confidential S-1 filed around June 8, 2026, with IPO targeting discussed up to $1 trillion (potentially 2027); prior secondary tender (October 2025) had cleared at $500 billion.[10][11]
• Forge Global data as of June 26–28, 2026, showed a per-share price implying ~$894 billion valuation.[9]

Comparative valuation table (mid-2026 data; multiples approximate EV/Revenue or ARR where applicable; public SaaS baseline ~3–6x with AI/growth premiums elevating leaders).[12]

• OpenAI: ~$25B ARR (Feb 2026); $852B primary (Mar 2026) / ~$895B secondary (Jun 2026) → ~34x ARR.
• Palantir: ~$6.5B+ ARR / Q1 2026 revenue $1.633B (85% YoY); market cap ~$271–300B (Jun 2026) → ~40–45x revenue (reports cite 20–43x range depending on exact forward/revenue base).[13][14]
• Salesforce: $41.5B FY2026 revenue (10% YoY); Agentforce/AI ARR components growing 169%+; market cap ~$130B (Jun 2026) → ~3x revenue.[15][16]
• Microsoft AI-related: $37B AI business run rate (reported Apr 2026, +123% YoY); embedded in larger Intelligent Cloud/Azure (~$75B+ annual Azure run rate context); overall MSFT market cap multi-trillion → effective AI-segment multiple significantly lower (diluted across diversified base with strong but not frontier-AI margins).

These figures show OpenAI and Palantir trading at 30–45x multiples driven by hyper-growth and AI positioning, far above mature SaaS like Salesforce at ~3x, while Microsoft’s AI contribution commands a blended premium within its broader portfolio. Secondary markets for OpenAI have remained liquid near the $852–900B range post-primary round, with IPO optionality discussed at up to $1T. Compute cost trajectories and Anthropic’s competing ARR claims (reportedly surpassing OpenAI in some Q2 2026 snapshots) remain key variables for whether these multiples compress or expand.

Traditional underwritten IPO is the most compatible mechanism for OpenAI’s PBC structure and nonprofit control.[1][2]

OpenAI restructured in 2025 into OpenAI Group PBC (a Delaware public benefit corporation) controlled by the OpenAI Foundation nonprofit, which holds approximately 26% equity (valued around $130 billion at recent targets). The PBC charter requires directors to balance shareholder value with the specific public benefit of ensuring AGI benefits humanity, plus stakeholder interests. This creates a dual-mandate fiduciary duty distinct from standard corporations.[3][4]

A traditional IPO (via confidential S-1 under SEC rules, followed by roadshow and priced offering) best accommodates this by enabling detailed prospectus disclosures on governance (e.g., nonprofit’s Class N or equivalent control rights to appoint directors and veto certain changes), mission balancing obligations, and risk factors around potential conflicts or litigation. Underwriters facilitate investor education on why the structure supports long-term mission alignment rather than pure profit maximization.[5]

Precedents from Mission-Driven or Controlled Tech Companies

• Veeva Systems: Reconstituted as a Delaware PBC around its public phase (market cap ~$50B at transition); it demonstrates PBCs can operate publicly with enhanced stakeholder focus while maintaining standard equity markets access.[6]
• Duolingo: Used a traditional IPO (2021) with dual-class shares preserving founder/control elements; this mirrors how OpenAI can layer nonprofit control atop PBC equity.
• Anthropic: Near-identical structure (PBC + Long-Term Benefit Trust for mission control) confidentially filed its own draft S-1 in early June 2026, validating the path for AI labs with retained nonprofit/mission oversight.[7]
• Patagonia: Chose a non-public steward-ownership model (Purpose Trust + nonprofit holding voting/economic interests) explicitly to avoid IPO/sale and lock in mission; this highlights why public markets favor PBC + traditional IPO over pure trust structures for capital-raising scale.[8]

Direct listings (e.g., Spotify precedent) lack underwriter support for explaining complex governance and typically suit companies with pre-existing liquidity, not $800B+ debutants needing broad investor buy-in. SPACs introduce reputational and dilution risks unsuitable for mega-cap, mission-sensitive listings.

Implication for competitors or entrants: A mission-driven company with retained nonprofit control should prioritize traditional IPOs with elite underwriters experienced in dual-class or controlled-company deals (e.g., Google/Alphabet, Meta). Early engagement on governance disclosures is critical; PBC conversion (as OpenAI did) is often a prerequisite for clean public-market acceptance.

Microsoft’s Equity Stake and Revenue-Sharing Agreement: Disclosure and Pre-IPO Adjustments

Microsoft holds roughly 27% of OpenAI Group PBC (valued ~$135 billion post-restructure) and maintains a reciprocal (primarily outbound from OpenAI) revenue-sharing deal at ~20% of relevant revenues, now subject to a total cap of $38 billion in payments, running through 2030 or AGI verification by an expert panel. Microsoft also retains exclusive IP licensing and Azure cloud rights until AGI.[9][10]

In an S-1, these must be disclosed as:
- Major shareholder ownership and voting/control implications.
- Material related-party transactions and contracts (revenue share, IP/cloud exclusivity) with quantified risks (e.g., payment caps, termination triggers).
- Potential conflicts with PBC duties (e.g., if revenue share or exclusivity prioritizes one stakeholder over mission).

Pre-IPO restructuring has already occurred: 2025–2026 partnership amendments capped revenue sharing, adjusted payment timelines, and clarified terms independent of certain tech milestones. No further wholesale conversion appears necessary, but supplemental amendments (e.g., waivers or side letters) could address any PBC-specific concerns. Full transparency mitigates investor concerns about governance capture.[11]

Implication: Strategic partners like Microsoft must accept heavy disclosure and potential minor tweaks; companies entering similar deals should negotiate IPO-friendly terms (caps, sunset provisions) upfront to avoid post-filing delays.

Public Underwriter Engagement and Filing Signals

OpenAI has engaged Goldman Sachs and Morgan Stanley as lead bookrunners (with internal firewalls for simultaneous Anthropic work); they are competing for “lead left” positioning. A confidential draft S-1 was submitted June 8, 2026 (shortly after Anthropic’s June 1 filing), following reported banker meetings and prep work in May 2026. The company has signaled a potential listing in late 2026 or 2027 (some reports note possible delay to 2027 amid market conditions), alongside employee tender offers.[5][12]

These signals align with a traditional IPO process rather than direct listing or SPAC. No public exchange discussions (e.g., Nasdaq vs. NYSE specifics) have emerged, but the scale favors major venues with experienced listings teams.

Implication: Early, high-caliber banker involvement signals readiness and credibility for complex structures. Rivals or similar companies should secure top-tier underwriters early and prepare for confidential filings to manage leaks and competitive timing.

Overall, OpenAI’s path validates traditional IPO as the scalable route for PBC/mission-controlled entities, provided governance is clearly articulated and major relationships are cleaned up and disclosed. This approach balances capital access with structural integrity better than alternatives.

Recent Findings Supplement (June 2026)

Traditional underwritten IPO via confidential S-1 is the path OpenAI has actively pursued in 2026, aligning with its PBC structure.[1]

OpenAI publicly confirmed on June 8, 2026, that it submitted a confidential draft S-1 registration statement to the SEC around May 22, 2026. This is the standard first step for a traditional underwritten IPO (not a direct listing or SPAC). The company is working with Goldman Sachs and Morgan Stanley as lead underwriters (with JPMorgan also involved per reports), positioning for a potential listing in late 2026 or, more recently, 2027 to target a ~$1 trillion valuation.[2]

This approach allows full regulatory review, roadshow marketing, and price discovery while accommodating the PBC’s dual fiduciary duties. No public signals have emerged for direct listings (which bypass traditional underwriting and roadshows) or SPACs (which involve merger vehicles and often face greater scrutiny on governance). Recent market volatility, including SpaceX’s post-IPO swings, has prompted advisers to favor a delay to 2027 over lowering the valuation target.[3]

OpenAI’s October 2025 restructuring into OpenAI Group PBC (with the OpenAI Foundation retaining control and a ~26% equity stake) is explicitly framed as IPO-compatible and draws on mission-driven precedents.[4]

The PBC requires balancing shareholder value with the company’s public benefit mission (AGI benefiting humanity), while the nonprofit Foundation maintains oversight and a large equity position (~$130 billion at recent valuations). This setup was completed in October 2025 with approvals from California and Delaware attorneys general and is described by OpenAI as simplifying the prior capped-profit model for capital raising and public markets.[5]

Precedents highlighted include Patagonia (PBC structure for purpose-driven operations) and Anthropic (another AI lab using PBC that filed its own confidential S-1 in early June 2026 at a ~$965 billion valuation). Veeva and Duolingo used traditional IPOs but without the same nonprofit-control overlay; OpenAI’s model extends the PBC approach to preserve mission control post-IPO.[6]

Microsoft’s ~27% equity stake (~$135 billion value) and the renegotiated revenue-sharing agreement will require standard related-party disclosures in the S-1, with the April 2026 amendments providing clearer economics.[7]

Post-October 2025 restructuring, Microsoft holds approximately 27% of OpenAI Group PBC on an as-converted diluted basis. In April 2026, the companies amended their partnership: OpenAI’s revenue-share payments to Microsoft (previously ~20% of revenue) continue through 2030 at the same percentage but are now subject to a total cap of $38 billion (saving OpenAI an estimated $97 billion versus prior projections). Microsoft ceased its own revenue-share payments to OpenAI, and the license became non-exclusive, allowing OpenAI greater cloud flexibility.[8]

These changes reduce long-term obligations and dependency risks (OpenAI still relies heavily on Azure), which must be disclosed as related-party transactions and risks in any S-1. Microsoft has already begun highlighting the stake in its own SEC filings. No further pre-IPO restructuring of the equity or core agreement has been announced.

Strong underwriter engagement is evident through the confidential S-1 and named banks, with no reported banker meetings or exchange-specific discussions beyond standard IPO preparation.[2]

Goldman Sachs and Morgan Stanley’s involvement (confirmed in connection with the May/June 2026 filing) signals active traditional IPO preparation, consistent with other mega-cap tech listings. OpenAI has noted it has not yet decided on timing and may pursue additional private-company actions first, while also planning an employee tender offer at the ~$852 billion valuation.[2]

Anthropic’s parallel confidential filing underscores a broader 2026 wave of AI IPOs via the traditional route. Overall, the PBC structure appears designed for, and is proceeding toward, a conventional underwritten IPO with full disclosures rather than alternative mechanisms.

OpenAI shows strong signals of preferring to remain private or significantly delaying an IPO beyond near-term targets (e.g., to 2027), driven by ample private funding, extreme infrastructure economics, governance frictions, and market precedents. Recent reporting (as of late June 2026) indicates the company is leaning toward a 2027 listing after confidential S-1 filing in May, citing SpaceX's post-IPO volatility and internal financial pressures.[1][2]

Here are the top structural and opinion-based disconfirming factors, ranked by strength of public evidence:

1. Sufficiency of Private Capital from Deep-Pocketed Strategic Partners and Sovereign Wealth Funds

OpenAI closed a record $122 billion funding round in March 2026 at an $852 billion post-money valuation, anchored by Amazon ($50B), Nvidia ($30B), and SoftBank ($30B), with participation from Microsoft, a16z, T. Rowe Price, Temasek, MGX (Abu Dhabi), and others. This followed earlier massive rounds (e.g., $40B+ in 2025) and included retail channels via banks. Additional SoftBank commitments and talks for up to $100B more rounds demonstrate that private markets—bolstered by hyperscalers seeking compute demand and sovereign funds—can sustain the company's needs without public equity.[3][4]

• These investors often structure deals with tranches, contingencies (e.g., tied to milestones or public status in some cases), and strategic offsets like cloud commitments, reducing pure dilution pressure.
  
• Private capital has already enabled valuations rivaling or exceeding many public tech giants, with secondary liquidity options expanding.
  

Implication: New entrants or competitors face a high bar; the private ecosystem for frontier AI is unusually deep and patient, lowering the urgency for an IPO liquidity event.

2. Compute Capex Scale Makes Public Market Economics Unattractive

OpenAI faces accelerating losses ($14B projected for 2026 alone, with cash burn rising sharply thereafter) and commitments exceeding $600B in infrastructure spend by 2030, including the $500B Stargate project and massive Oracle/Azure deals (e.g., $300B+ over years). Gross margins sit around 33% due to inference costs, with breakeven not expected before 2029. Public markets have shown limited appetite for such prolonged, capital-intensive burn at trillion-dollar valuations, especially amid broader tech volatility.[5][6]

• Q1 2026 examples highlight capex dominance (e.g., tens of billions annualized), functioning like leveraged obligations ahead of equity holders.
  
• CFO Sarah Friar has cited ongoing cash burn and infrastructure commitments as reasons for caution on timing.[7]

Implication: Public investors demand clearer paths to profitability and free cash flow; heavy capex profiles risk multiple contraction or muted demand, making staying private (with flexible private investors) more rational.

3. AI Valuation Multiple Compression Risks in Public Markets

Broader software and tech multiples have compressed significantly (e.g., application software EV/NTM revenue multiples down ~41% YoY to 3.4x in early 2026 data points, well below historical averages). AI-exposed names face scrutiny on sustainability amid hyperscaler capex debates and competition. SpaceX's post-IPO share slump (from record highs) has directly influenced OpenAI advisers to recommend delay for better retail/investor enthusiasm.[8][9]

• Private valuations (e.g., $852B–$1T targets) embed aggressive growth assumptions that public markets may re-rate downward upon fuller disclosure of margins and competition.
  
• Analysts note public AI infrastructure spend is already facing pushback despite private enthusiasm.

Implication: An IPO at current private marks carries high execution risk of immediate de-rating; delaying preserves optionality as fundamentals (revenue, margins) improve.

4. Governance Complexity Raises Public Disclosure and Operational Costs

OpenAI operates as a Public Benefit Corporation (PBC) with the OpenAI Foundation (nonprofit) retaining ~26% equity but 100% board appointment rights, creating mission-profit tensions, safety vetoes, and Microsoft revenue-sharing complexities. Additional issues include Altman’s personal investments (e.g., in energy firms with potential OpenAI overlap) and historical restructuring scrutiny. Public company reporting would require detailed disclosure of these arrangements, related-party deals, and conflicts—unusual and costly for a frontier lab.[10][11]

• Friar has highlighted the “burden of public reporting” as a factor in preferring delay.[7]
  
• This structure is precedent-setting and adds layers of risk (e.g., shareholder suits over control or mission drift) not present in standard corporations.

Implication: Competitors with simpler structures may find public markets more accessible; OpenAI’s setup incentivizes remaining private to avoid scrutiny and retain mission-aligned control.

5. Precedents of Frontier AI Labs Remaining Private (or Delaying)

Anthropic (confidential S-1 filed June 2026, potential 2026/2027 IPO but market-dependent; recently overtook OpenAI on some private valuation metrics) and xAI (merged into SpaceX, which pursued IPO amid volatility but with Musk’s history of long private phases) illustrate that top labs can sustain massive scale privately. Reports frame these as testing public waters flexibly rather than rushing.[12][13]

• SpaceX’s $1.77T debut followed by declines serves as a cautionary live example for OpenAI deliberations.
  
• Private markets have supported these firms through enormous raises without forcing liquidity.

Implication: The “IPO or bust” thesis is overstated; private persistence is viable and increasingly normalized for AI leaders, pressuring public market terms.

6. Statements from OpenAI Insiders and Board/Aligned Voices Favoring Caution or Privacy

CFO Sarah Friar stated in late 2025 that an IPO was “not on the cards” in the near term, emphasizing financial shoring-up, and has internally raised concerns about readiness, burn rates, and organizational gaps for a 2026 listing—reportedly pushing for 2027. Altman has insisted on a $1T valuation (calling lower targets a “nonstarter”), but advisers and market realities have shifted the consensus toward delay.[14][1]

• Recent reports note internal divisions, with Friar sidelined in some discussions yet her caution influencing the pivot.
  
• Broader board/foundation oversight adds layers preferring mission continuity over rapid public transition.

Implication: Leadership alignment leans pragmatic over aggressive IPO timelines; this internal preference, backed by capital access, strengthens the case against near-term listing.

Overall, these factors collectively suggest the IPO thesis is overstated for the near-to-medium term (through at least 2027). Private capital depth, capex realities, governance frictions, and peer examples create powerful incentives and precedents for extended privacy. Competitors or investors evaluating entry should model scenarios around sustained private funding rounds rather than assuming public market access as inevitable or imminent.

Recent Findings Supplement (June 2026)

OpenAI has secured massive private funding sufficient to support aggressive compute expansion without immediate public-market access. In February 2026, the company announced a $110 billion investment round at a $730 billion pre-money valuation, including $30 billion from SoftBank, $30 billion from NVIDIA, and $50 billion from Amazon.[1] SoftBank has committed over $60 billion total (with more than $30 billion already deployed), targeting roughly 13% ownership through tranches completed or scheduled in April, July, and October 2026; this follows earlier investments and contributed to a subsequent $852 billion valuation in a March 2026 round.[2][3][4] Additional large investors participated in later rounds, demonstrating continued private-capital appetite at scale.[5]

This influx funds data-center and infrastructure buildout while keeping the company private, reducing pressure for an IPO to access liquidity or capital.

Compute capex and operating losses create economics that public markets may penalize heavily. OpenAI faces rising inference costs (projected at $14.1 billion in 2026) amid ongoing heavy losses, with reports of roughly $13 billion in 2025 revenue against $34 billion in spend and a ~$21 billion operating loss.[6][7] The company has committed to an estimated $1.4 trillion in data-center and infrastructure capex over eight years and does not expect profitability until 2030, while burning more than $1 per dollar of revenue in some projections.[8][9] Public investors have shown sensitivity to such sustained burn rates and dilution risks, especially amid broader AI multiple-compression concerns.

Recent internal deliberations point to a potential delay until 2027 to preserve a high valuation target. A June 25, 2026 New York Times report, citing people involved in deliberations, stated that OpenAI is leaning toward holding its IPO until 2027 to target a $1 trillion valuation rather than accepting a lower figure for a 2026 debut; CEO Sam Altman reportedly called any reduction in the trillion-dollar target a “nonstarter.”[10][10] This follows earlier comments from CFO Sarah Friar (late 2025) that the company was not pursuing an IPO at that time while focusing on finances, and aligns with OpenAI’s own June 8, 2026 statement after its confidential S-1 filing: timing is undecided and “may be a while” because certain activities are easier as a private company, though the filing preserves the option for a sooner listing if needed.[11]

Governance complexity raises disclosure costs and potential valuation discounts. OpenAI’s structure as a public benefit corporation (PBC) controlled by a nonprofit foundation (post-2025 recapitalization) is unusual at this scale and could invite heightened regulatory and investor scrutiny over control, mission alignment, and related-party elements (e.g., Microsoft’s stake and rights).[6][12][13] Analysts have noted that public-market investors may demand discounts for this governance setup compared with purely for-profit peers, increasing the relative cost of going public versus remaining private with tailored investor agreements.

Precedents and market signals favor extended privacy for frontier AI labs. xAI was acquired by SpaceX in February 2026 (valued at ~$250 billion in the deal) and integrated rather than pursuing a standalone IPO, illustrating a path of remaining effectively private within a larger entity.[14][15] While Anthropic confidentially filed for an IPO in June 2026 (targeting near-$1 trillion), OpenAI-specific reporting highlights caution tied to post-SpaceX IPO performance and fears of fading AI premiums.[16][17] A January 2026 analysis explicitly predicted Anthropic would go public in 2026 while OpenAI would not.[18]

These factors—particularly the June 2026 reporting on deliberate pacing and the scale of private capital—collectively suggest the near-to-medium-term IPO case is weaker than sometimes assumed, with OpenAI appearing positioned to sustain operations privately while optimizing for a higher eventual valuation or alternative structures.